Medmonk GTM brain

category

market profile

• text: Patient access programs coordinate benefits investigation, prior authorization, financial assistance and ongoing support for prescribed therapies.
• text: The company says its network covers 98% of US pharmacies and buy-and-bill facilities; this is a company claim.
• text: An independent profile identifies an actual manufacturer copay portal administered by Medmonk, while noting that most performance metrics are company reported.

personas

• title: Pharma director of market access
  pains:

  • Coverage and affordability barriers delay treatment starts
  • Fragmented hub and pharmacy workflows obscure program performance
• title: Specialty or rare disease brand manager
  pains:

  • High out-of-pocket costs contribute to prescription abandonment
  • The brand needs visibility into reach and program ROI
• title: Patient support hub operations leader
  pains:

  • Benefits investigations and authorizations consume staff time
  • Complex specialty therapies require coordinated case management

icp

• text: US pharmaceutical manufacturers with branded specialty or rare disease therapies and patient support budgets.
• text: Market access organizations operating copay, reimbursement and pharmacy programs across medical and pharmacy benefits; company size is unspecified.

message pillars

• text: Connect access work to more therapy starts.
• text: Enroll patients at the pharmacy point of sale.
• text: Make brand program performance visible.
• text: Combine operational technology with clinical expertise.

objections

• objection: Will this integrate with our existing patient support and pharmacy workflows?
  response: Review the stated FHIR APIs and scope an integration pilot with the actual EHR, CRM and pharmacy systems.
• objection: Can sensitive patient information be handled appropriately?
  response: Request current security and HIPAA documentation, a data flow review and contractual safeguards.
• objection: Are promised performance metrics relevant to our drug?
  response: Request references and baseline-to-pilot results for a comparable therapy and population.

competitors

• name: GoodRx
  why: Its manufacturer solutions business distributes copay offers through a pharmacy network.
• name: RareMed Solutions
  why: Provides rare disease hub services and specialty patient support.

influencers

• name: Ashar Hasan
  url: https://www.linkedin.com/posts/ashar-hasan-r-ph-mba-56b41b74_in-2006-i-acquired-a-specialty-pharmacy-activity-7466130011943559169-SOv1
  why: CEO discussing his specialty pharmacy experience and Medmonk's approach.

keywords

• pharma patient support hub
• copay assistance platform
• specialty therapy patient access
• pharma market access technology
• patient assistance program automation
• pharmacy copay enrollment

voice

• commercial and outcome-focused
• patient access oriented
• partnership-led

signals

• text: A manufacturer is launching a specialty or rare disease therapy with a new support program.
• text: A market access team is redesigning copay enrollment or seeking better visibility into therapy starts.

stack

• FHIR APIs

pricing

motion

channels

• website
• LinkedIn
• industry events

confidence

Founders

• name: Abbas Mehdi
  title: Founder
  role: Founder
• name: Somaira Punjwani
  title: Founder
  role: Founder